APA (7th ed.) Citation

Bellos, I., Lagiou, P., Benetou, V., & Marinaki, S. (2024). Safety and Efficacy of Sodium-Glucose Transport Protein 2 Inhibitors and Glucagon-like Peptide-1 Receptor Agonists in Diabetic Kidney Transplant Recipients: Synthesis of Evidence. Journal of Clinical Medicine, 13(20), 6181. https://doi.org/10.3390/jcm13206181

Chicago Style (17th ed.) Citation

Bellos, Ioannis, Pagona Lagiou, Vassiliki Benetou, and Smaragdi Marinaki. "Safety and Efficacy of Sodium-Glucose Transport Protein 2 Inhibitors and Glucagon-like Peptide-1 Receptor Agonists in Diabetic Kidney Transplant Recipients: Synthesis of Evidence." Journal of Clinical Medicine 13, no. 20 (2024): 6181. https://doi.org/10.3390/jcm13206181.

MLA (9th ed.) Citation

Bellos, Ioannis, et al. "Safety and Efficacy of Sodium-Glucose Transport Protein 2 Inhibitors and Glucagon-like Peptide-1 Receptor Agonists in Diabetic Kidney Transplant Recipients: Synthesis of Evidence." Journal of Clinical Medicine, vol. 13, no. 20, 2024, p. 6181, https://doi.org/10.3390/jcm13206181.